Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DGPisano
    Junior Member
    • Feb 2010
    • 2

    #1

    Bioinformatician at CNIO, Madrid, Spain

    Bioinformatician for the Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain

    Description:
    The Human Genetics Group is looking for a bioinformatician with experience in data analysis generated by massive sequencing in order to investigate and analyze families with cancer.

    We require:
    • A PhD or BD in any area of Molecular Biology.
    • More than three years of experience in Bioinformatics with publications in this area and molecular biology.
    • Development of bioinformatics software in general, good knowledge of data bases and methodology of massive sequencing
    • Good knowledge of the literature about cancer genome and genetic diseases.
    • Capacity for projects management and cooperation in international projects


    We offer:

    A job in an excellence Centre which has multiple national and international collaborations. Salary is depending of the experience and degree. The incorporation would be immediate.

    Candidates will contact with [email protected] including his/her CV and at least two reference names

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...